HopeStage
Back to all studies
CompletedNCT03537040

Helping People Think Through Antipsychotic Medication Choices

About this titleRead the official source — NCT03537040
Interventional studyAges 16+United KingdomSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 16 years.

Listed locations
Preston and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: June 27, 2018
Recruitment status
Completed
Enrollment listed in the registry
5
Sponsor
University of Manchester
Sponsor type
University
Study type
Other
Intervention type
Other
Locations
United Kingdom
Age range
Over 16 Years
Official registry ID
NCT03537040
Official title
Show the full official title

A Pilot Study to Assess the Feasibility and Acceptability of a Novel Intervention to Help People Think About Their Neuroleptic Medication Use.

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Preston · Manchester

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Manchester, a university.

Who was this study for?

Listed age limits: from 16 years.

Want to explore more studies?

Explore studies